Acquisition strengthens position in Niche Markets

The successful acquisition of Erweka, a highly regarded German developer and manufacturer of tablet testing equipment, has been proudly announced by the Verder Group.

Becoming an integral part of Verder Scientific, its complementary technology brings the opportunity to accelerate the division’s trajectory in targeted niche markets. Founded in 1951, Erweka’s manufacturing and assembly facility in Langen, (near Frankfurt) and sales offices in the US and Hong Kong, have  supplied dissolution and tablet testing equipment to pharmaceutical and life science companies, research and test laboratories and universities all over the world.

Verder Group Founder/Owner and CEO Andries Verder expressed his enthusiasm: "We are excited to welcome Erweka into the Verder family. Its strong market position and exceptional expertise perfectly complement the Verder Scientific existing portfolio. Together, we will unlock new possibilities, accelerate innovation and create synergies that benefit our customers, employees and stakeholders."

Erweka CEO Claudia Müller stated: “Today (May 25) marks an exciting milestone as our technology driven company joins forces with Verder Scientific. Together, we embark on a journey that not only guarantees a future-proof and robust foundation but also unveils unprecedented growth possibilities. Our shared vision is rooted in the belief that technology, when harnessed strategically, can transform lives and businesses alike.”

 Dr Jürgen Pankratz, CEO Verder Scientific Instruments Division stated: “We will take our time to deeply understand the customer’s needs and dynamics of this new business segment. I have no doubt that subsequently we will jointly derive a business plan that will make significant contributions to the future growth and success of Erweka.”

More information online